96 related articles for article (PubMed ID: 18422875)
1. In vivo measurement of vascular modulation in experimental tumors using a fluorescent contrast agent.
Valentini G; D'Andrea C; Ferrari R; Pifferi A; Cubeddu R; Martinelli M; Natoli C; Ubezio P; Giavazzi R
Photochem Photobiol; 2008; 84(5):1249-56. PubMed ID: 18422875
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging measurements of the response of murine and human tumors to the vascular-targeting agent ZD6126.
Evelhoch JL; LoRusso PM; He Z; DelProposto Z; Polin L; Corbett TH; Langmuir P; Wheeler C; Stone A; Leadbetter J; Ryan AJ; Blakey DC; Waterton JC
Clin Cancer Res; 2004 Jun; 10(11):3650-7. PubMed ID: 15173071
[TBL] [Abstract][Full Text] [Related]
3. Assessment of unspecific near-infrared dyes in laser-induced fluorescence imaging of experimental arthritis.
Fischer T; Gemeinhardt I; Wagner S; Stieglitz DV; Schnorr J; Hermann KG; Ebert B; Petzelt D; Macdonald R; Licha K; Schirner M; Krenn V; Kamradt T; Taupitz M
Acad Radiol; 2006 Jan; 13(1):4-13. PubMed ID: 16399028
[TBL] [Abstract][Full Text] [Related]
4. Effects of the vascular disrupting agent ZD6126 on interstitial fluid pressure and cell survival in tumors.
Skliarenko JV; Lunt SJ; Gordon ML; Vitkin A; Milosevic M; Hill RP
Cancer Res; 2006 Feb; 66(4):2074-80. PubMed ID: 16489007
[TBL] [Abstract][Full Text] [Related]
5. Fluorescent liposomes as contrast agents for in vivo optical imaging of edemas in mice.
Deissler V; Rüger R; Frank W; Fahr A; Kaiser WA; Hilger I
Small; 2008 Aug; 4(8):1240-6. PubMed ID: 18666163
[TBL] [Abstract][Full Text] [Related]
6. Indocyanine green: physicochemical factors affecting its fluorescence in vivo.
Mordon S; Devoisselle JM; Soulie-Begu S; Desmettre T
Microvasc Res; 1998 Mar; 55(2):146-52. PubMed ID: 9521889
[TBL] [Abstract][Full Text] [Related]
7. Optical antisense imaging of tumor with fluorescent DNA duplexes.
Liu X; Wang Y; Nakamura K; Liu G; Dou S; Kubo A; Rusckowski M; Hnatowich DJ
Bioconjug Chem; 2007; 18(6):1905-11. PubMed ID: 17939728
[TBL] [Abstract][Full Text] [Related]
8. Functional optical detection based on pH dependent fluorescence lifetime.
Gannot I; Ron I; Hekmat F; Chernomordik V; Gandjbakhche A
Lasers Surg Med; 2004; 35(5):342-8. PubMed ID: 15611954
[TBL] [Abstract][Full Text] [Related]
9. Optical imaging of cancer heterogeneity with multispectral optoacoustic tomography.
Herzog E; Taruttis A; Beziere N; Lutich AA; Razansky D; Ntziachristos V
Radiology; 2012 May; 263(2):461-8. PubMed ID: 22517960
[TBL] [Abstract][Full Text] [Related]
10. Imaging of cerebrospinal fluid space and movement in mice using near infrared fluorescence.
Shibata Y; Kruskal JB; Palmer MR
J Neurosci Methods; 2005 Sep; 147(2):82-7. PubMed ID: 15885798
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of in vivo multichannel optical imaging of gene expression: experimental study in mice.
Mahmood U; Tung CH; Tang Y; Weissleder R
Radiology; 2002 Aug; 224(2):446-51. PubMed ID: 12147841
[TBL] [Abstract][Full Text] [Related]
12. Detecting vascular-targeting effects of the hypoxic cytotoxin tirapazamine in tumor xenografts using magnetic resonance imaging.
Bains LJ; Baker JH; Kyle AH; Minchinton AI; Reinsberg SA
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):957-65. PubMed ID: 19480975
[TBL] [Abstract][Full Text] [Related]
13. Real-time identification of liver cancers by using indocyanine green fluorescent imaging.
Ishizawa T; Fukushima N; Shibahara J; Masuda K; Tamura S; Aoki T; Hasegawa K; Beck Y; Fukayama M; Kokudo N
Cancer; 2009 Jun; 115(11):2491-504. PubMed ID: 19326450
[TBL] [Abstract][Full Text] [Related]
14. The use of fluorescent dyes and probes in surgical oncology.
Te Velde EA; Veerman T; Subramaniam V; Ruers T
Eur J Surg Oncol; 2010 Jan; 36(1):6-15. PubMed ID: 19926438
[TBL] [Abstract][Full Text] [Related]
15. Molecular imaging of factor XIIIa activity in thrombosis using a novel, near-infrared fluorescent contrast agent that covalently links to thrombi.
Jaffer FA; Tung CH; Wykrzykowska JJ; Ho NH; Houng AK; Reed GL; Weissleder R
Circulation; 2004 Jul; 110(2):170-6. PubMed ID: 15210587
[TBL] [Abstract][Full Text] [Related]
16. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic-rate images of indocyanine green for breast tumors using near-infrared optical methods.
Alacam B; Yazici B; Intes X; Nioka S; Chance B
Phys Med Biol; 2008 Feb; 53(4):837-59. PubMed ID: 18263944
[TBL] [Abstract][Full Text] [Related]
18. Peptide-based MRI contrast agent and near-infrared fluorescent probe for intratumoral legumain detection.
Chen YJ; Wu SC; Chen CY; Tzou SC; Cheng TL; Huang YF; Yuan SS; Wang YM
Biomaterials; 2014 Jan; 35(1):304-15. PubMed ID: 24120038
[TBL] [Abstract][Full Text] [Related]
19. Time-resolved detection of fluorescent light during inflow of ICG to the brain-a methodological study.
Milej D; Gerega A; Zołek N; Weigl W; Kacprzak M; Sawosz P; Mączewska J; Fronczewska K; Mayzner-Zawadzka E; Królicki L; Maniewski R; Liebert A
Phys Med Biol; 2012 Oct; 57(20):6725-42. PubMed ID: 23032301
[TBL] [Abstract][Full Text] [Related]
20. The vascular disrupting agent ZD6126 shows increased antitumor efficacy and enhanced radiation response in large, advanced tumors.
Siemann DW; Rojiani AM
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):846-53. PubMed ID: 15936569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
